EU AI Act
EU regulation establishing risk-based requirements for AI systems, including most medical AI.
Definition
Regulation (EU) 2024/1689 classifies AI systems by risk. Medical-device AI is generally treated as 'high-risk' and must meet AI Act requirements (data governance, transparency, human oversight, robustness, post-market monitoring) in addition to MDR/IVDR. The AI Act entered into force on August 1, 2024, with obligations phased in. For AI systems that are safety components of, or are themselves, devices requiring notified body assessment under the MDR or IVDR, high-risk obligations apply from August 2, 2027. The AI Act assessment is integrated into the existing MDR or IVDR conformity assessment, so one notified body can review both, as long as it is designated for the AI Act.What this means in practice
Conformity assessment for medical AI is integrated with the existing Notified Body process. Phased application runs through 2027; manufacturers should align technical documentation now.Examples
- A manufacturer developing an AI-powered diagnostic imaging system must demonstrate robust data governance practices for the AI model's training data, as per AI Act requirements.
- An AI-enabled surgical robot requires clear human oversight mechanisms, allowing medical professionals to intervene or override AI decisions, in line with the EU AI Act.
- A company marketing an AI algorithm for disease prediction must establish a comprehensive post-market monitoring system to track the AI's performance and address any emerging risks or biases.
- •Failing to integrate AI Act requirements into technical documentation early will lead to significant delays in market access.
- •Assuming that MDR/IVDR compliance alone is sufficient for AI-powered medical devices is a critical error.
- •Neglecting to establish robust post-market monitoring for AI systems will result in non-compliance and potential regulatory action.
- •Misinterpreting the "high-risk" classification criteria for AI in medical devices can lead to inadequate conformity assessment.
- •Overlooking the need for human oversight mechanisms in AI-driven medical devices will result in non-adherence to the Act.
Frequently asked questions
Cross-references
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsMedical device that uses artificial intelligence or machine learning to perform its intended use.
Regulation (EU) 2017/746 governing in vitro diagnostic medical devices in the EU.
Regulation (EU) 2017/745 governing medical devices in the European Union.
EU-designated organization that assesses conformity of medical devices under MDR and IVDR.
More in Software & AI
· Same categoryAAMI Technical Information Report providing guidance on applying Agile software development practices within an IEC 62304-compliant medical device software lifecycle.
Resilience of an ML model to inputs deliberately crafted to cause misclassification.
The detailed procedural section of a PCCP that specifies how planned modifications to an AI/ML model will be developed, validated, and implemented.
Systematic differences in model performance across demographic or clinical subgroups.
Where this term appears across MedTech Terms.
Latest in MedTech
Sources
3 sourcesEvery citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
- 1EU AI Act (Reg. 2024/1689)Tier 1 VerifiedEUR-Lexeur-lex.europa.eu
- 2IMDRF - Software as a Medical DeviceTier 2 VerifiedIMDRFimdrf.org
- 3MDCG Software GuidanceTier 2 VerifiedMDCGhealth.ec.europa.eu
Inline markers like [1] jump to the matching reference above.